Glaucoma Drug Fails Trial, But Bausch + Lomb Sees Opportunity in Another Eye DiseaseNews DeskJuly 10, 20260 Bausch + Lomb is dropping plans to develop a drug for glaucoma after the experimental treatment failed a mid-stage clinical…